ArticleFrontiers in immunology2023

Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies.

Paul Noe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.